+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Transport of fluorescein methotrexate by multidrug resistance-associated protein 3 in IEC-6 cells



Transport of fluorescein methotrexate by multidrug resistance-associated protein 3 in IEC-6 cells



American Journal of Physiology. Gastrointestinal and Liver Physiology 285(3): G602-G610



The transport characteristics of fluorescein methotrexate (F-MTX) were studied by using the rat intestinal crypt cell line IEC-6. Enhanced accumulation of F-MTX at 4 degrees C suggests the existence of an active efflux system. MK-571, an inhibitor of the multidrug resistance-associated protein/ATP binding cassette C (MRP/ABCC) family, also enhanced the accumulation of F-MTX. Transcellular transport of F-MTX from the apical to the basolateral compartment was 2.5 times higher than the opposite direction. This vectorial transport was also reduced by MK-571, indicating the presence of Mrp-type transporter(s) on the basolateral membrane. Mrp3 mRNA was readily detectable, and the protein was localized on the basolateral membrane. Uptake of FMTX into membrane vesicles from IEC-6 cells and Spodoptera frugiperda-9 cells expressing rat Mrp3 were both ATP dependent and saturable as a function of the F-MTX concentration. Similar Km values (11.0 +/- 1.8 and 4.5 +/- 1.1 microM) and inhibition profiles by MK-571, estradiol-17beta-d-glucuronide, and taurocholate for the ATP-dependent transport of F-MTX into these vesicles were obtained. These findings suggest that the efflux of F-MTX is mediated by Mrp3 on the basolateral membrane of IEC-6 cells.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011589022

Download citation: RISBibTeXText

PMID: 12909565

DOI: 10.1152/ajpgi.00424.2002


Related references

Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Research 62(11): 3144-3150, 2002

Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Research 61(19): 7225-7232, 2001

Transport of methotrexate and folates by multidrug resistance protein 3 and MRP1 Effect of polyglutamylation on MTX transport. Cancer Research 61(19): 7225-7232, October 1, 2001

Multidrug resistance modulation by the taxane derivatives IDN-5109 and tRA96023 Effects on P-glycoprotein -, multidrug resistance protein -, and breast cancer resistance protein - mediated drug transport. Proceedings of the American Association for Cancer Research Annual Meeting 43: 950, March, 2002

Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3. British Journal of Cancer 75(2): 161-168, 1997

Resistance to mitoxantrone in multidrug-resistant MCF7 breast cancer cells: evaluation of mitoxantrone transport and the role of multidrug resistance protein family proteins. Cancer Research 61(14): 5461-5467, 2001

Evidence for multiple mechanisms of methotrexate resistance in cells displaying atypical multidrug resistance following selection solely with high concentration methotrexate. Proceedings of the American Association for Cancer Research Annual Meeting 31: 372, 1990

Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2- and MRP4/ABCC4-mediated methotrexate transport. Journal of Pharmacology and Experimental Therapeutics 320(1): 229-235, 2006

Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2-and MRP4/ABCC4-mediated methotrexate transport. Journal of Pharmacology and Experimental Therapeutics 320(1): 229-235, 2007

Kinetic analysis of fluorescein and dihydrofluorescein effluxes in tumour cells expressing the multidrug resistance protein, MRP1. Biochemical Pharmacology 65(6): 969-977, 15 March, 2003

Involvement of P-glycoprotein, multidrug resistance protein 2 and breast cancer resistance protein in the transport of belotecan and topotecan in Caco-2 and MDCKII cells. Pharmaceutical Research 25(11): 2601-2612, 2008

Nuclear multidrug-resistance related protein 1 contributes to multidrug-resistance of mucoepidermoid carcinoma mainly via regulating multidrug-resistance protein 1: a human mucoepidermoid carcinoma cells model and Spearman's rank correlation analysis. Plos One 8(8): E69611-E69611, 2014

The Pipecolinate Derivatives VX-710 and VX-853 Are Effective Modulators of Drug Efflux Mediated by the Multidrug Resistance Proteins P-Glycoprotein, Multidrug Resistance Protein and Breast Cancer Resistance Protein in Acute Myeloid Leukemia Cells. Blood 100(11): Abstract No 245, November 16, 2002

Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. Journal of Biological Chemistry 276(41): 38108-38114, 2001